reboxetine has been researched along with enkephalin, d-penicillamine (2,5)- in 1 studies
Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (enkephalin, d-penicillamine (2,5)-) | Trials (enkephalin, d-penicillamine (2,5)-) | Recent Studies (post-2010) (enkephalin, d-penicillamine (2,5)-) |
---|---|---|---|---|---|
626 | 193 | 184 | 1,314 | 0 | 73 |
Protein | Taxonomy | reboxetine (IC50) | enkephalin, d-penicillamine (2,5)- (IC50) |
---|---|---|---|
Mu-type opioid receptor | Homo sapiens (human) | 0.0016 | |
Delta-type opioid receptor | Homo sapiens (human) | 0.0011 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carpentier, C; Costentin, J; Leroux-Nicollet, I; Naudon, L; Vilpoux, C | 1 |
1 other study(ies) available for reboxetine and enkephalin, d-penicillamine (2,5)-
Article | Year |
---|---|
Differential effects of chronic antidepressant treatments on micro- and delta-opioid receptors in rat brain.
Topics: Animals; Antidepressive Agents; Autoradiography; Binding Sites; Brain; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Injections, Intraperitoneal; Male; Moclobemide; Morpholines; Paroxetine; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Opioid, delta; Receptors, Opioid, mu; Time Factors | 2002 |